Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Inogen, Inc.
  6. Summary
    INGN   US45780L1044

INOGEN, INC.

(INGN)
  Report
Real-time Estimate Cboe BZX  -  11:23 2022-08-12 am EDT
30.69 USD   +1.82%
08/04INOGEN : Q2 Earnings Snapshot
AQ
08/04TRANSCRIPT : Inogen, Inc., Q2 2022 Earnings Call, Aug 04, 2022
CI
08/04Earnings Flash (INGN) INOGEN Reports Q2 Revenue $103.4M
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/08/2022 08/09/2022 08/10/2022 08/11/2022 08/12/2022 Date
27.61(c) 27.61(c) 28.19(c) 30.14(c) 30.57 Last
209 297 272 946 290 192 231 700 18 035 Volume
-0.36% 0.00% +2.10% +6.92% +1.43% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 374 M - -
Net income 2022 -37,1 M - -
Net cash position 2022 242 M - -
P/E ratio 2022 -18,6x
Yield 2022 -
Sales 2023 411 M - -
Net income 2023 -24,3 M - -
Net cash position 2023 270 M - -
P/E ratio 2023 -29,1x
Yield 2023 -
Capitalization 688 M 688 M -
EV / Sales 2022 1,19x
EV / Sales 2023 1,02x
Nbr of Employees 1 021
Free-Float 98,3%
More Financials
Company
Inogen, Inc. is a medical technology company, which provides respiratory products for use in the homecare setting. The Company primarily develops, manufactures, and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One systems concentrate the air around the patient to offer a single source of supplemental... 
Read more
More about the company
Ratings of Inogen, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about INOGEN, INC.
08/04INOGEN : Q2 Earnings Snapshot
AQ
08/04TRANSCRIPT : Inogen, Inc., Q2 2022 Earnings Call, Aug 04, 2022
CI
08/04Earnings Flash (INGN) INOGEN Reports Q2 Revenue $103.4M
MT
08/04Earnings Flash (INGN) INOGEN Posts Q2 Loss $-0.02
MT
08/04INOGEN : Announces Second Quarter 2022 Financial Results - Form 8-K
PU
08/04INOGEN INC : Management's Discussion and Analysis of Financial Condition and Results of Op..
AQ
08/04Inogen Announces Second Quarter 2022 Financial Results
BU
08/04Inogen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June ..
CI
07/07Inogen to Announce Second Quarter 2022 Financial Results on August 4, 2022
BU
06/24INOGEN, INC.(NASDAQGS : INGN) added to Russell 3000 Value Index
CI
06/24INOGEN, INC.(NASDAQGS : INGN) added to Russell Microcap Value Index
CI
06/24INOGEN, INC.(NASDAQGS : INGN) dropped from Russell 2000 Growth-Defensive Index
CI
06/24INOGEN, INC.(NASDAQGS : INGN) added to Russell 2000 Value Index
CI
06/24INOGEN, INC.(NASDAQGS : INGN) added to Russell Microcap Growth Index
CI
06/24INOGEN, INC.(NASDAQGS : INGN) added to Russell 3000E Index
CI
More news
News in other languages on INOGEN, INC.
08/04Earnings Flash (INGN) INOGEN annonce un chiffre d'affaires de 103,4 millions de dollars..
08/04Inogen, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 30..
05/18Inogen, Inc. nomme Agnes Lee au poste de vice-présidente principale des relations avec ..
05/05Earnings Flash (INGN) INOGEN annonce un chiffre d'affaires de 80,4 millions de dollars ..
05/05Inogen, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2022
More news
Analyst Recommendations on INOGEN, INC.
More recommendations
Chart INOGEN, INC.
Duration : Period :
Inogen, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INOGEN, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 30,14 $
Average target price 35,67 $
Spread / Average Target 18,3%
EPS Revisions
Managers and Directors
Nabil Shabshab President, Chief Executive Officer & Director
Kristin A. Caltrider Treasurer, Chief Financial & Accounting Officer
Elizabeth A. Mora Chairman
Stanislav Glezer Chief Technology Officer
Bart Sanford Executive Vice President-Operations
Sector and Competitors
1st jan.Capi. (M$)
INOGEN, INC.-11.35%688
ABBOTT LABORATORIES-21.49%193 492
MEDTRONIC PLC-9.10%124 952
BECTON, DICKINSON AND COMPANY5.55%73 980
HOYA CORPORATION-17.18%38 478
SARTORIUS STEDIM BIOTECH-19.69%36 875